LATEST NEWS
Solasia Acquires License For ZIOPHARM’s Darinaparsin
ZIOPHARM could receive up to US$72.2 million from Solasia for the anti-cancer drug darinaparsin.
Can Singapore Be A Technopreneurship Leader?
Dr. Stephen Turner, CTO and founder of Pacific Biosciences, shares his perspectives on the innovation culture in Singapore.
Spinning Solar Cells Into Textiles
Solar cell fibers that can be woven into textiles could power the next generation of wearable devices.
New Drug Could Tackle Dengue
A study shows that Celgosivir could potentially be used to treat dengue fever, a disease for which antivirals currently do not exist.
The Long Road To Financial Derivative Reform
How can we avoid a repeat of the 2008 global financial crisis? SMU Assistant Professor Christopher Chen looks at how today’s huge financial derivatives market can be better regulated for the benefit of the global economy and individual financial consumer.
Good Vs Greed: Balancing Social Norms And Financial Rewards
SMU Assistant Professor Liu Yanju examines how economic agents make decisions when faced with the choice of behaving ethically or increasing their financial gain.
Resource Allocation: Is There A Fair Way To Slice Up The Pie?
SMU Professor of Economics Shurojit Chatterji designs mechanisms that countries can use to allocate their scarce resources more fairly and efficiently.
Investigating The Economics Of Childcare
Assistant Professor Christine Ho of the SMU School of Economics notes that childcare subsidies should be designed with the family in mind.
Could IITs Help Engineers Embrace The Humanities?
IITs do have existing humanities and social science programs, but could do more to offer a comprehensive education, Dr. Pushkar writes.
